Publications by authors named "Seiichi Mawatari"

Claim this Profile
C
Cause-specific mortality following sustained virologic response in hepatitis C patients treated with direct-acting antivirals: a standardized mortality ratio analysis.
Seiichi Mawatari, Shiroh Tanoue, Kotaro Kumagai, Kohei Oda, Ai Toyodome

Sci Rep· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Posttreatment serum CXCL10 level stratifies survival in compensated and decompensated cirrhotic patients due to chronic hepatitis C virus infection after direct-acting antiviral therapy.
Takanori Suzuki, Kentaro Matsuura, Yuki Tahata, Hayato Hikita, Ryotaro Sakamori, Seiichi Mawatari

J Gastroenterol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Continuous Intravenous Infusion of Hepatocyte Growth Factor Promotes the Development of a Fibrolytic Phenotype in Hepatic Macrophages and Stellate Cells in a Rat Model of Bile Duct Ligation.
Oki Taniyama, Kotaro Kumagai, Shuji Kanmura, Yuko Nakamura, Hiromi Eguchi, Seiichi Mawatari

Hepatol Res· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pretreatment serum angiopoietin-2 predicts prognosis and liver functional reserve after successful HCV eradication with sofosbuvir and velpatasvir in patients with HCV-related decompensated cirrhosis.
Naoki Kawagishi, Goki Suda, Yuki Tahata, Hayato Hikita, Takahiro Kodama, Seiichi Mawatari

J Gastroenterol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum Growth Differentiation Factor 15 Can Be a Novel Biomarker to Predict the Prognosis of Patients With Hepatitis C Virus Cirrhosis After Virus Elimination.
Yuta Myojin, Hayato Hikita, Yuki Tahata, Kenji Fukumoto, Seiya Kato, Seiichi Mawatari

Hepatol Res· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison Analysis of Lenvatinib Plus Transcatheter Arterial Chemoembolization Versus Atezolizumab Plus Bevacizumab as First-Line Therapy for Intermediate-Stage Hepatocellular Carcinoma Beyond the Up-to-Seven Criteria.
Takashi Niizeki, Seiichi Mawatari, Michihiko Shibata, Ryu Sasaki, Shinji Itoh

J Gastroenterol Hepatol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fontan-Associated Liver Disease: Predictors of Elevated Liver Stiffness and the Role of Transient Elastography in Long-Term Follow-Up.
Haruka Sakae, Shiroh Tanoue, Seiichi Mawatari, Kohei Oda, Ohki Taniyama

Cureus· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Thyrotoxicosis induced by immune checkpoint inhibitor therapy for unresectable hepatocellular carcinoma:a case report].
Yu Yamazato, Tsutomu Tamai, Sho Ijuin, Seiichi Mawatari, Kaori Muromachi

Nihon Shokakibyo Gakkai Zasshi· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood pressure elevations post-lenvatinib treatment in hepatocellular carcinoma: a potential marker for better prognosis.
Keisuke Shibata, Yuichi Akasaki, Akihiro Tokushige, Mina Nitta, Shin Kawasoe, Seiichi Mawatari

Hypertens Res· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of the susceptibility of refractory hepatitis C virus resistant to nonstructural 5A inhibitors.
Ai Toyodome, Seiichi Mawatari, Hiromi Eguchi, Midori Takeda, Kotaro Kumagai

Sci Rep· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Skill Proficiency, Efficacy, and Safety of the Transradial Approach in Transarterial Treatments for Hepatocellular Carcinoma.
Kyo Sasaki, Yusuke Kawamura, Chikara Ogawa, Kazuhisa Yabushita, Shoji Watanabe, Seiichi Mawatari

Cureus· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Magnetic resonance imaging-based risk factors of hepatocellular carcinoma after direct-acting antiviral therapy: A multicenter observational study.
Shintaro Ichikawa, Utaroh Motosugi, Yoshiyuki Sawai, Hisashi Ishida, Yasuharu Imai, Seiichi Mawatari

Hepatol Res· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Usefulness of the aldehyde breath test for predicting metachronous recurrence in patients with esophageal squamous cell carcinoma and hypopharyngeal squamous cell carcinoma.
Fumisato Sasaki, Seiichi Mawatari, Kohei Oda, Hiroki Yano, Hidehito Maeda

Esophagus· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glycoprotein non-metastatic melanoma protein B expression correlates with the prognosis of acute liver injury/failure.
Kotaro Kumagai, Shuji Kanmura, Seiichi Mawatari, Yuko Nakamura, Hiromi Eguchi

Front Cell Dev Biol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful Percutaneous Transhepatic Obliteration Plus Sengstaken-Blakemore Tube Combination Therapy for Recurrent Gastroesophageal Variceal Bleeding.
Ai Toyodome, Tsutomu Tamai, Fumisato Sasaki, Masafumi Hashiguchi, Ohki Taniyama, Seiichi Mawatari

Intern Med· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A case of acute liver failure due to aggressive natural killer-cell leukemia with a rapid course.
Ai Toyodome, Seiichi Mawatari, Ohki Taniyama, Sho Ijuin, Haruka Sakae

Clin J Gastroenterol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a risk prediction score and equation for chronic kidney disease: a retrospective cohort study.
Shin Kawasoe, Takuro Kubozono, Anwar Ahmed Salim, Haruhito Yoshimine, Seiichi Mawatari

Sci Rep· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early-phase prothrombin time-international normalized ratio in acute liver injury indicates the timing of therapeutic intervention and predicts prognostic improvement.
Kotaro Kumagai, Seiichi Mawatari, Akihiro Moriuchi, Kohei Oda, Yasuhiro Takikawa

Hepatol Res· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Effect of Lenvatinib Re-Administration after Transcatheter Arterial Chemoembolization in Patients with Intermediate Stage Hepatocellular Carcinoma.
Seiichi Mawatari, Tsutomu Tamai, Kotaro Kumagai, Akiko Saisyoji, Kaori Muromachi

Cancers (Basel)· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Efficacy and Safety of Atezolizumab Plus Bevacizumab and Lenvatinib as First-Line Therapy for Unresectable Hepatocellular Carcinoma: A Propensity Score Matching Analysis.
Takashi Niizeki, Takayuki Tokunaga, Yuko Takami, Yoshiyuki Wada, Masaru Harada, Seiichi Mawatari

Target Oncol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A case of autoimmune hepatitis with thymoma and myasthenia gravis.
Haruka Sakae, Seiichi Mawatari, Kohei Oda, Kazuaki Tabu, Kotaro Kumagai

Clin J Gastroenterol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Features of patients who developed hepatocellular carcinoma after direct-acting antiviral treatment for hepatitis C Virus.
Seiichi Mawatari, Kotaro Kumagai, Kohei Oda, Kazuaki Tabu, Sho Ijuin

PLoS One· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serine palmitoyltransferase long chain subunit 3 is associated with hepatocellular carcinoma in patients with NAFLD.
Sho Ijuin, Kohei Oda, Seiichi Mawatari, Ohki Taniyama, Ai Toyodome

Mol Clin Oncol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trends in hepatocellular carcinoma incident cases in Japan between 1996 and 2019.
Masahito Nakano, Hiroshi Yatsuhashi, Shigemune Bekki, Yuko Takami, Yasuhito Tanaka, Seiichi Mawatari

Sci Rep· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Highly sensitive agglutinin-reactive fraction of α-fetoprotein is a predictive marker for hepatocarcinogenesis in long-term observation of patients with chronic liver disease.
Kazuaki Tabu, Seiichi Mawatari, Kohei Oda, Ohki Taniyama, Ai Toyodome

Mol Clin Oncol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis